TrialReproductive health2017

Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial.

Sarah Nakubulwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.